Literature DB >> 15129883

Interpreting differences in quality of life: the FACT-H&N in laryngeal cancer patients.

Jolie Ringash1, Andrea Bezjak, Brian O'Sullivan, Donald A Redelmeier.   

Abstract

UNLABELLED: Quality of life (QOL) scores can be difficult to interpret, because small statistically significant differences can be clinically unimportant. Our goal was to estimate the magnitude of difference in QOL that is noticeable to patients.
METHODS: Laryngeal cancer patients (n = 98, male = 83%, mean age = 65) completed a QOL questionnaire, FACT-H&N. Paired participants rated their own QOL as compared to each other. We estimated the smallest difference in QOL score that was associated with a noticeable difference in patients' subjective ratings.
RESULTS: Differences in FACT-H&amp;N score were somewhat correlated with patients' ratings of their well-being relative to other patients (r = 0.195, p < 0.0001). The FACT-H&amp;N score had to differ by 6.22 for patients to rate themselves as 'a little bit better' relative to other patients (95% CI: 1.42-11.02), and by 12.40 for patients to rate themselves as 'a little bit worse' relative to others (95% CI: 5.09-19.71). Results were consistent regardless of patient age, gender or laryngeal subsite but were imperfect predictors of individual judgements.
CONCLUSION: The minimal important difference for the FACT-H&amp;N score is about 6-12 units, but laryngeal cancer survivors may be more sensitive to gains than losses.

Entities:  

Mesh:

Year:  2004        PMID: 15129883     DOI: 10.1023/B:QURE.0000021703.47079.46

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  22 in total

Review 1.  Optimistic biases about personal risks.

Authors:  N D Weinstein
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

2.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Authors:  Gregory T Wolf; Susan Gross Fisher; Waun Ki Hong; Robert Hillman; Monica Spaulding; George E Laramore; James W Endicott; Kenneth McClatchey; William G Henderson
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

3.  Evaluating measurement responsiveness.

Authors:  M H Liang
Journal:  J Rheumatol       Date:  1995-06       Impact factor: 4.666

4.  Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients.

Authors:  D A Redelmeier; A M Bayoumi; R S Goldstein; G H Guyatt
Journal:  Am J Respir Crit Care Med       Date:  1997-04       Impact factor: 21.405

Review 5.  Interpretation of quality of life changes.

Authors:  E Lydick; R S Epstein
Journal:  Qual Life Res       Date:  1993-06       Impact factor: 4.147

6.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

Authors:  E F Juniper; G H Guyatt; A Willan; L E Griffith
Journal:  J Clin Epidemiol       Date:  1994-01       Impact factor: 6.437

Review 7.  A structured review of quality of life instruments for head and neck cancer patients.

Authors:  J Ringash; A Bezjak
Journal:  Head Neck       Date:  2001-03       Impact factor: 3.147

8.  Quality of life and utility in irradiated laryngeal cancer patients.

Authors:  J Ringash; D A Redelmeier; B O'Sullivan; A Bezjak
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-07-01       Impact factor: 7.038

9.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

Authors:  D F Cella; D S Tulsky; G Gray; B Sarafian; E Linn; A Bonomi; M Silberman; S B Yellen; P Winicour; J Brannon
Journal:  J Clin Oncol       Date:  1993-03       Impact factor: 44.544

10.  Minimum important difference between patients with rheumatoid arthritis: the patient's perspective.

Authors:  G A Wells; P Tugwell; G R Kraag; P R Baker; J Groh; D A Redelmeier
Journal:  J Rheumatol       Date:  1993-03       Impact factor: 4.666

View more
  23 in total

1.  A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores.

Authors:  Susan Yount; Marcy List; Hongyan Du; Kathleen Yost; Rita Bode; Bruce Brockstein; Athanassios Argiris; Everett Vokes; Ezra E W Cohen; Bruce Campbell; Veronica Valenzuela; Jacquelyn George; Robyn Egan; Jessica Chen; David Meddis; David Cella
Journal:  Qual Life Res       Date:  2007-10-06       Impact factor: 4.147

Review 2.  Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: a methodological review.

Authors:  Susanne Singer; Juan Ignacio Arraras; Wei-Chu Chie; Sheila E Fisher; Razvan Galalae; Eva Hammerlid; Ourania Nicolatou-Galitis; Claudia Schmalz; Irma Verdonck-de Leeuw; Eva Gamper; Judith Keszte; Dirk Hofmeister
Journal:  Qual Life Res       Date:  2012-11-28       Impact factor: 4.147

3.  Development and validation of the nasopharyngeal cancer scale among the system of quality of life instruments for cancer patients (QLICP-NA V2.0): combined classical test theory and generalizability theory.

Authors:  Jiayuan Wu; Liren Hu; Gaohua Zhang; Qilian Liang; Qiong Meng; Chonghua Wan
Journal:  Qual Life Res       Date:  2016-02-29       Impact factor: 4.147

4.  The ENHANCES study: a randomised controlled trial of a nurse-led survivorship intervention for patients treated for head and neck cancer.

Authors:  Jane Turner; Patsy Yates; Lizbeth Kenny; Louisa G Gordon; Bryan Burmeister; Brett G M Hughes; Alexandra L McCarthy; Chris Perry; Raymond J Chan; Alana Paviour; Helen Skerman; Martin Batstone; Lisa Mackenzie
Journal:  Support Care Cancer       Date:  2019-04-02       Impact factor: 3.603

5.  Neuromuscular function and fatigability in people diagnosed with head and neck cancer before versus after treatment.

Authors:  Colin Lavigne; Harold Lau; George Francis; S Nicole Culos-Reed; Guillaume Y Millet; Rosie Twomey
Journal:  Eur J Appl Physiol       Date:  2020-04-06       Impact factor: 3.078

6.  Development and validation of the simplified Chinese version of EORTC QLQ-H&N35 for patients with head and neck cancer.

Authors:  Zheng Yang; Qiong Meng; Jiahong Luo; Qian Lu; Xiaojiang Li; Gaofeng Li; Chonghua Wan
Journal:  Support Care Cancer       Date:  2011-08-18       Impact factor: 3.603

7.  Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials.

Authors:  John T Maringwa; Chantal Quinten; Madeleine King; Jolie Ringash; David Osoba; Corneel Coens; Francesca Martinelli; Jurgen Vercauteren; Charles S Cleeland; Henning Flechtner; Carolyn Gotay; Eva Greimel; Martin J Taphoorn; Bryce B Reeve; Joseph Schmucker-Von Koch; Joachim Weis; Egbert F Smit; Jan P van Meerbeeck; Andrew Bottomley
Journal:  Support Care Cancer       Date:  2010-10-01       Impact factor: 3.603

8.  Comparison of distribution- and anchor-based approaches to infer changes in health-related quality of life of prostate cancer survivors.

Authors:  Ravishankar Jayadevappa; Stanley Bruce Malkowicz; Marsha Wittink; Alan J Wein; Sumedha Chhatre
Journal:  Health Serv Res       Date:  2012-03-14       Impact factor: 3.402

9.  PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions.

Authors:  Karon F Cook; Sally E Jensen; Benjamin D Schalet; Jennifer L Beaumont; Dagmar Amtmann; Susan Czajkowski; Darren A Dewalt; James F Fries; Paul A Pilkonis; Bryce B Reeve; Arthur A Stone; Kevin P Weinfurt; David Cella
Journal:  J Clin Epidemiol       Date:  2016-03-04       Impact factor: 6.437

10.  Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.

Authors:  Patrick D Maguire; Charles R Neal; Stuart M Hardy; Andrew M Schreiber
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-12-28       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.